Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.

Balamurugan K, Mendoza-Villanueva D, Sharan S, Summers GH, Dobrolecki LE, Lewis MT, Sterneck E.

Oncogene. 2019 May;38(20):3765-3780. doi: 10.1038/s41388-018-0516-5. Epub 2018 Sep 27.

2.

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT.

J Cancer. 2017 Oct 9;8(17):3607-3614. doi: 10.7150/jca.21200. eCollection 2017.

3.

The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.

Mendoza-Villanueva D, Balamurugan K, Ali HR, Kim SR, Sharan S, Johnson RC, Merchant AS, Caldas C, Landberg G, Sterneck E.

Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.

4.

C/EBPδ deficiency sensitizes mice to ionizing radiation-induced hematopoietic and intestinal injury.

Pawar SA, Shao L, Chang J, Wang W, Pathak R, Zhu X, Wang J, Hendrickson H, Boerma M, Sterneck E, Zhou D, Hauer-Jensen M.

PLoS One. 2014 Apr 18;9(4):e94967. doi: 10.1371/journal.pone.0094967. eCollection 2014.

5.

The many faces of C/EBPδ and their relevance for inflammation and cancer.

Balamurugan K, Sterneck E.

Int J Biol Sci. 2013 Sep 20;9(9):917-33. doi: 10.7150/ijbs.7224. eCollection 2013. Review.

6.

Positional variations in mammary gland development and cancer.

Veltmaat JM, Ramsdell AF, Sterneck E.

J Mammary Gland Biol Neoplasia. 2013 Jun;18(2):179-88. doi: 10.1007/s10911-013-9287-3. Epub 2013 May 12. Review.

7.

FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.

Balamurugan K, Sharan S, Klarmann KD, Zhang Y, Coppola V, Summers GH, Roger T, Morrison DK, Keller JR, Sterneck E.

Nat Commun. 2013;4:1662. doi: 10.1038/ncomms2677.

8.

Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Sarkar TR, Sharan S, Wang J, Pawar SA, Cantwell CA, Johnson PF, Morrison DK, Wang JM, Sterneck E.

Mol Cell Biol. 2012 Jan;32(2):320-32. doi: 10.1128/MCB.05790-11. Epub 2011 Oct 28.

9.

CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.

Ko CY, Chang LH, Lee YC, Sterneck E, Cheng CP, Chen SH, Huang AM, Tseng JT, Wang JM.

Neurobiol Aging. 2012 Feb;33(2):422.e11-25. doi: 10.1016/j.neurobiolaging.2010.09.017. Epub 2010 Nov 26.

10.

The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, Sterneck E.

EMBO J. 2010 Dec 15;29(24):4106-17. doi: 10.1038/emboj.2010.280. Epub 2010 Nov 12.

11.

CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.

Pan YC, Li CF, Ko CY, Pan MH, Chen PJ, Tseng JT, Wu WC, Chang WC, Huang AM, Sterneck E, Wang JM.

Clin Cancer Res. 2010 Dec 1;16(23):5770-80. doi: 10.1158/1078-0432.CCR-10-1025. Epub 2010 Oct 22.

12.

CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.

Wang J, Sarkar TR, Zhou M, Sharan S, Ritt DA, Veenstra TD, Morrison DK, Huang AM, Sterneck E.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16131-6. doi: 10.1073/pnas.1002603107. Epub 2010 Aug 30.

13.

C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.

Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9210-5. doi: 10.1073/pnas.0913813107. Epub 2010 May 3.

14.

Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells.

Hour TC, Lai YL, Kuan CI, Chou CK, Wang JM, Tu HY, Hu HT, Lin CS, Wu WJ, Pu YS, Sterneck E, Huang AM.

Biochem Pharmacol. 2010 Aug 1;80(3):325-34. doi: 10.1016/j.bcp.2010.04.007. Epub 2010 Apr 10.

15.

MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility.

Fan HY, Liu Z, Shimada M, Sterneck E, Johnson PF, Hedrick SM, Richards JS.

Science. 2009 May 15;324(5929):938-41. doi: 10.1126/science.1171396.

16.

Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB.

Smink JJ, Bégay V, Schoenmaker T, Sterneck E, de Vries TJ, Leutz A.

EMBO J. 2009 Jun 17;28(12):1769-81. doi: 10.1038/emboj.2009.127. Epub 2009 May 14.

17.

CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression.

Tomita T, Kido T, Kurotani R, Iemura S, Sterneck E, Natsume T, Vinson C, Kimura S.

J Biol Chem. 2008 Sep 12;283(37):25617-27. doi: 10.1074/jbc.M805140200. Epub 2008 Jul 16.

18.

The Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function.

Huang AM, Rudelius M, Sharan S, McAllister JM, Raffeld M, Christenson LK, Sterneck E.

PLoS One. 2007 Dec 19;2(12):e1334.

19.

SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases.

Thangaraju M, Gopal E, Martin PM, Ananth S, Smith SB, Prasad PD, Sterneck E, Ganapathy V.

Cancer Res. 2006 Dec 15;66(24):11560-4.

20.

c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney.

Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, Prasad PD, Ganapathy V.

J Biol Chem. 2006 Sep 15;281(37):26769-73. Epub 2006 Jul 26.

21.

Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis.

Sterneck E, Zhu S, Ramirez A, Jorcano JL, Smart RC.

Oncogene. 2006 Feb 23;25(8):1272-1276. doi: 10.1038/sj.onc.1209144.

22.

C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution.

Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang AM, Sterneck E.

Development. 2005 Nov;132(21):4675-85. Epub 2005 Sep 28.

23.

Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta.

Burkart AD, Mukherjee A, Sterneck E, Johnson PF, Mayo KE.

Endocrinology. 2005 Apr;146(4):1909-21. Epub 2005 Jan 13.

PMID:
15650079
25.

Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability.

Huang AM, Montagna C, Sharan S, Ni Y, Ried T, Sterneck E.

Oncogene. 2004 Feb 26;23(8):1549-57.

PMID:
14716301
26.

Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia.

Gigliotti AP, Johnson PF, Sterneck E, DeWille JW.

Exp Biol Med (Maywood). 2003 Mar;228(3):278-85.

PMID:
12626772
27.

An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis.

Ménard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabé-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD.

Neuron. 2002 Nov 14;36(4):597-610.

28.

C306A single nucleotide polymorphism in the human CEBPD gene that maps at 8p11.1-p11.2.

Angeloni D, Lee JD, Johnson BE, Teh BT, Dean M, Lerman MI, Sterneck E.

Mol Cell Probes. 2001 Dec;15(6):395-7. No abstract available.

PMID:
11851384
29.

CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):207-12. Epub 2001 Dec 26.

30.
31.

C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression.

Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, Smart RC.

Mol Cell Biol. 1999 Oct;19(10):7181-90.

32.

STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.

Tinnell SB, Jacobs-Helber SM, Sterneck E, Sawyer ST, Conrad DH.

Int Immunol. 1998 Oct;10(10):1529-38.

PMID:
9796920
33.

Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta.

Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L, Crawley JN, Johnson PF.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10908-13.

34.

The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland.

Robinson GW, Johnson PF, Hennighausen L, Sterneck E.

Genes Dev. 1998 Jun 15;12(12):1907-16.

35.

C/EBPalpha is a regulator of the UDP glucuronosyltransferase UGT2B1 gene.

Hansen AJ, Lee YH, Sterneck E, Gonzalez FJ, Mackenzie PI.

Mol Pharmacol. 1998 Jun;53(6):1027-33.

PMID:
9614204
37.

Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.

Cantwell CA, Sterneck E, Johnson PF.

Mol Cell Biol. 1998 Apr;18(4):2108-17.

38.

An essential role for C/EBPbeta in female reproduction.

Sterneck E, Tessarollo L, Johnson PF.

Genes Dev. 1997 Sep 1;11(17):2153-62.

39.

The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain.

Lee YH, Williams SC, Baer M, Sterneck E, Gonzalez FJ, Johnson PF.

Mol Cell Biol. 1997 Apr;17(4):2038-47.

40.
41.

Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motif.

Haas JG, Ströbel M, Leutz A, Wendelgass P, Müller C, Sterneck E, Riethmüller G, Ziegler-Heitbrock HW.

J Immunol. 1992 Jul 1;149(1):237-43.

PMID:
1607656
44.

Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor.

Leutz A, Damm K, Sterneck E, Kowenz E, Ness S, Frank R, Gausepohl H, Pan YC, Smart J, Hayman M, et al.

EMBO J. 1989 Jan;8(1):175-81.

Supplemental Content

Loading ...
Support Center